CIK 0001253689 · Non-accelerated filer<br>Smaller reporting company
CRESCENT BIOPHARMA, INC.
Sign in to watch- Ticker
- CBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- operating
- Phone
- 617-430-5595
- Business address
- 300 FIFTH AVENUE, WALTHAM, MA, 02451
- Former names
- GLYCOMIMETICS INC
- 10-K Report Annual Report
- PRE 14A Proxy Proxy Statement (Preliminary)
- 8-K Event Regulation FD disclosure
- SC 13D/A Stake Beneficial Ownership Report
- SC 13D/A Stake Beneficial Ownership Report
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Material agreement
- 4 Grant or award Director acquired 5,191 shares (grant or award)
- 4 Grant or award Director acquired 4,238 shares (grant or award)
- 4 Grant or award Director acquired 5,827 shares (grant or award)
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 4 Grant or award Director acquired 9,167 shares (grant or award)
- 4 Grant or award Director acquired 8,167 shares (grant or award)
Page 11 of 34 · 678 filings